Efficacy Of Lenalidomide In Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts And An Extreme Platelet Count
CLINICAL CASE REPORTS(2020)
摘要
Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN-RS-T in the context of major platelet counts.
更多查看译文
关键词
lenalidomide, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombosis, myeloproliferative syndrome, thrombocytosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要